National Costs Associated With Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010–2014 | Zendy

Eili Klein | Zendy; Wendi Jiang | Zendy; Nestor Mojica | Zendy; Katie K Tseng | Zendy; Ryan McNeill | Zendy; Sara E. Cosgrove | Zendy; Trish M. Perl | Zendy

Open Access

National Costs Associated With Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010–2014

Author(s) -

Eili Klein,

Wendi Jiang,

Nestor Mojica,

Katie K Tseng,

Ryan McNeill,

Sara E. Cosgrove,

Trish M. Perl

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy399

Subject(s) - methicillin resistant staphylococcus aureus , staphylococcus aureus , medicine , staphylococcal infections , health care , intensive care medicine , microbiology and biotechnology , emergency medicine , biology , bacteria , economics , genetics , economic growth

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) have been associated with worse patient outcomes and higher costs of care than methicillin-susceptible (MSSA) infections. However, since prior studies found these differences, the healthcare landscape has changed, including widespread dissemination of community-associated strains of MRSA. We sought to provide updated estimates of the excess costs of MRSA infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research